Enfusion, Inc. (NYSE:ENFN) CFO Bradley Herring Sells 1,533 Shares

Enfusion, Inc. (NYSE:ENFN) CFO Bradley Herring sold 1,533 shares of Enfusion stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $11.48, for a total transaction of $17,598.84. Following the transaction, the chief financial officer now directly owns 329,334 shares in the company, valued at $3,780,754.32. The trade was a 0.46 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Bradley Herring also recently made the following trade(s):

• On Tuesday, January 7th, Bradley Herring sold 4,134 shares of Enfusion stock. The stock was sold at an average price of $10.13, for a total transaction of $41,877.42.
• On Friday, December 20th, Bradley Herring sold 24,443 shares of Enfusion stock. The shares were sold at an average price of $10.61, for a total transaction of $259,340.23.

Enfusion Trading Up 0.4 %

Enfusion stock opened at $11.45 on Thursday. The company has a fifty day simple moving average of $10.95 and a 200 day simple moving average of $9.85. Enfusion, Inc. has a 1-year low of $7.83 and a 1-year high of $11.80. The company has a market cap of $1.47 billion, a P/E ratio of 286.20, a price-to-earnings-growth ratio of 1.85 and a beta of 0.96.

Enfusion (NYSE:ENFN) last released its earnings results on Monday, March 3rd. The company reported $0.01 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.02). Enfusion had a net margin of 1.70% and a return on equity of 6.67%. The company had revenue of $52.94 million during the quarter, compared to analyst estimates of $53.98 million. On average, equities research analysts forecast that Enfusion, Inc. will post 0.06 EPS for the current year.

Hedge Funds Weigh In On Enfusion

A number of institutional investors have recently added to or reduced their stakes in ENFN. KLP Kapitalforvaltning AS acquired a new position in shares of Enfusion during the 4th quarter worth about $75,000. Millennium Management LLC bought a new position in Enfusion during the fourth quarter worth about $114,000. Harbor Capital Advisors Inc. increased its position in Enfusion by 12.4% during the third quarter. Harbor Capital Advisors Inc. now owns 11,887 shares of the company’s stock worth $113,000 after buying an additional 1,315 shares during the last quarter. Belvedere Trading LLC bought a new stake in Enfusion in the third quarter valued at approximately $114,000. Finally, Dark Forest Capital Management LP acquired a new stake in shares of Enfusion in the fourth quarter valued at approximately $128,000. 81.05% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms have weighed in on ENFN. Piper Sandler lifted their target price on Enfusion from $10.00 to $11.50 and gave the stock a “neutral” rating in a report on Monday, December 23rd. Stifel Nicolaus increased their target price on Enfusion from $11.00 to $13.00 and gave the stock a “buy” rating in a research note on Wednesday, December 18th. Finally, William Blair reaffirmed a “market perform” rating on shares of Enfusion in a research note on Monday, January 13th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $11.13.

About Enfusion

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.